US2006003405A1PendingUtilityA1
Method of expressing recombinant protein in cho cells
Est. expiryJul 18, 2022(expired)· nominal 20-yr term from priority
C12N 2830/42C12N 15/907C12N 2800/108C12N 2840/20
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Method of expressing recombinant protein in CHO cells, by using an expression vector comprising the murine IgG 2A gene locus.
Claims
exact text as granted — not AI-modified1 - 8 . (canceled)
9 . CHO cell transfected with an expression vector comprising a promoter that is active in CHO cells and that is driving expression of a recombinant product protein and further comprising a portion from the murine IgA 2A gene locus DNA which portion is enhancing activity of said promoter.
10 . CHO cell according to claim 9 , characterized in that the vector further comprises a transcription unit encoding a selectable marker, preferably a glutamin synthetase (GS) marker.
11 . CHO cell according to claim 9 or 10 , characterized in the CHO cell is stably transfected.
12 . Method of expressing a recombinant protein, comprising the steps of culturing a CHO cell transfected with an expression vector comprising a promoter active in CHO cells driving expression of a recombinant product protein and further comprising the murine IgA 2A gene locus DNA or a DNA sequence variant or DNA fragment thereof which is enhancing activity of said promoter, and harvesting the product protein
13 . Method according to claim 12 , characterised in that the promoter is a strong viral promoter, preferably the hCMV promoter.
14 . Method according to one of claims 12 or 13 , characterised in that the IgA 2A gene locus portion does lack the natural immunoglobulin promoter.
15 . Method according to claim 12 , characterized in that the promoter is hCMV promoter or a functional part thereof having promoter activity wherein said promoter or functional part lack the ‘modulator’ sequence in the upstream/enhancer portion as found stretching from position −750 to −1150 relative to the MIE transcription start site.
16 . CHO cell transfected with a mammalian expression vector comprising at least a first transcription unit for a product gene which transcription unit is under the control of the mCMV promoter, and further comprising a second transcription unit comprising a glutamine synthetase (GS) marker gene.
17 . Mammalian expression vector comprising at least a first transcription unit for a product gene which transcription unit is under control of the mCMV promoter or a functional fragment thereof, and further comprising a second transcription unit comprising a glutamine synthetase (GS) marker gene.
18 . Vector according to claim 16 , wherein the mCMV promoter or functional fragment comprises the natural transcription start site (+0) and extends upstream to position −500.
19 . Vector according to claim 18 , wherein the mCMV promoter or functional fragment extends to the natural Xho l restriction site.
20 . Vector according to claim 18 , wherein the transcription start site is engineered to comprise a suitable restriction site for insertion of a recombinant gene product.
21 . Vector according to claim 17 or 18 , wherein the first transcription unit harbors at least one intron sequence.
22 . Vector according to claim 21 , wherein said intron is not the first, natural intron of the mCMV promoter.
23 . Method of using 17 for enhancing the transfection rate in CHO cells.Join the waitlist — get patent alerts
Track US2006003405A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.